CARE Ratings Ltd Falls 4.07%: Key Technical Shifts and Upgrade Drive Volatility

18 May: Golden Cross Formation Sparks Initial Optimism

CARE Ratings Ltd began the week with a significant technical event as its 50-day moving average crossed above the 200-day moving average, forming a Golden Cross. This classic bullish indicator suggested a potential long-term trend reversal and renewed upward momentum. Despite this positive signal, the stock closed the day at Rs.1,728.00, down 4.07%, contrasting with the Sensex’s modest decline of 0.35%. The sharp price drop on the day may reflect profit-taking or short-term volatility despite the technical optimism.

The Golden Cross was supported by bullish weekly MACD and KST indicators, while monthly signals remained neutral to mildly bearish. The Relative Strength Index (RSI) on a weekly basis was bearish, indicating some short-term selling pressure. On-balance volume (OBV) trends were positive on a monthly scale, suggesting accumulation over time. The stock’s market capitalisation stood at approximately Rs.5,274 crores, with a P/E ratio of 30.28, slightly below the industry average.

18 May: Technical Momentum Shifts to Mildly Bullish Outlook

Alongside the Golden Cross, CARE Ratings exhibited a shift from sideways to mildly bullish momentum. The stock traded within a range of Rs.1,750.00 to Rs.1,836.00, approaching its 52-week high of Rs.1,964.80. Over the past week, the stock had outperformed the Sensex significantly, delivering an 8.94% return compared to the benchmark’s 2.70% decline.

Technical indicators presented a nuanced picture: weekly MACD was bullish, monthly MACD mildly bearish; weekly RSI bearish, monthly RSI neutral; Bollinger Bands showed bullish signals on both weekly and monthly charts. Daily moving averages were mildly bearish, reflecting recent consolidation. The Know Sure Thing (KST) oscillator was mildly bullish weekly but bearish monthly. These mixed signals suggested a transitional phase with cautious optimism.

21 May: Upgrade to Buy Rating on Strong Financials and Bullish Technicals

MarketsMOJO upgraded CARE Ratings Ltd from a 'Hold' to a 'Buy' rating on 20 May 2026, reflecting improved fundamentals and technical momentum. The Mojo Score rose to 71.0, signalling increased confidence in the stock’s prospects. The upgrade was supported by robust financial metrics including a net-debt-free status, 11 consecutive quarters of profitability, and a half-year ROCE of 24.81%.

Profit before tax excluding other income grew 28.77% year-on-year to Rs.56.30 crores, while net profit after tax increased 24.0% to Rs.52.83 crores. Institutional investors held a significant 54.63% stake, underscoring strong market confidence. Despite a premium price-to-book ratio of 5.6 and a PEG ratio of 1.3, the valuation was considered justified by earnings growth.

Technical indicators showed a bullish weekly MACD and daily moving averages, though monthly MACD and RSI remained mildly bearish or neutral. The stock traded within a 52-week range of Rs.1,393.95 to Rs.1,964.80, closing the day at Rs.1,719.55, down 2.04%. The upgrade reflected a balanced view of strong earnings momentum tempered by valuation and longer-term growth considerations.

21 May: Technical Momentum Signals Bullish Outlook Amid Market Volatility

On the same day as the rating upgrade, CARE Ratings’ technical momentum shifted further towards a bullish stance despite a 2.04% intraday decline. Weekly MACD was firmly bullish, daily moving averages supported upward momentum, and On-Balance Volume (OBV) indicated accumulation. However, the weekly RSI remained bearish, signalling short-term consolidation or selling pressure.

Bollinger Bands were mildly bullish weekly and bullish monthly, with the stock price near the upper band on the monthly chart, suggesting potential for further gains. The Know Sure Thing (KST) oscillator was bullish weekly but mildly bearish monthly, reflecting mixed signals across timeframes. Dow Theory assessments showed a mildly bullish monthly trend but no clear weekly trend.

The stock’s relative performance remained strong, delivering a 7.03% return over the past week compared to the Sensex’s 0.95% gain. Year-to-date, CARE Ratings was up 7.41% while the Sensex declined 11.62%. These metrics highlighted the stock’s resilience amid broader market volatility.

22 May: Modest Recovery on Final Trading Day

CARE Ratings closed the week at Rs.1,727.95, up 0.78% on 22 May, recovering slightly from the midweek declines. The Sensex also gained 0.21% on the day, continuing its modest upward trend. The stock’s volume increased to 2,387 shares, indicating renewed buying interest. Despite the recovery, the weekly performance remained negative at -4.07%, underperforming the Sensex’s 0.50% gain for the week.

This price action reflected ongoing volatility and mixed investor sentiment, with technical indicators suggesting a cautiously optimistic outlook. The stock’s ability to hold above Rs.1,700 support levels will be critical in the near term as it navigates the balance between bullish momentum and valuation concerns.

Key Takeaways

Positive Signals: The Golden Cross formation early in the week marked a significant technical milestone, signalling potential for a sustained upward trend. The upgrade to a Buy rating by MarketsMOJO on 20 May reflected strong financials, including consistent profitability, high ROCE, and institutional backing. Weekly MACD and Bollinger Bands indicated bullish momentum, supported by positive volume trends.

Cautionary Notes: Despite these positives, the stock faced notable volatility, with a sharp 4.07% decline on 18 May and a weekly loss of the same magnitude. Weekly RSI remained bearish, suggesting short-term selling pressure. Monthly technical indicators such as MACD and KST were mildly bearish, indicating longer-term caution. The stock’s premium valuation metrics, including a high price-to-book ratio and PEG above 1, warrant careful monitoring of growth expectations.

Relative Performance: CARE Ratings underperformed the Sensex this week, falling 4.07% while the benchmark gained 0.50%. However, the stock’s longer-term returns remain impressive, with three- and five-year gains well above the Sensex. This resilience highlights the company’s strong fundamentals and sector positioning despite short-term volatility.

Conclusion

CARE Ratings Ltd’s week was marked by a blend of technical optimism and price volatility. The Golden Cross and rating upgrade provided a foundation for bullish sentiment, yet the stock’s price action reflected caution amid mixed technical signals and valuation concerns. While the stock closed the week lower, its relative strength over longer periods and improving fundamentals suggest that the recent weakness may be a consolidation phase rather than a reversal.

Investors should watch key support levels near Rs.1,700 and resistance around Rs.1,960, alongside evolving technical indicators and quarterly results, to gauge the sustainability of the current momentum. The stock’s small-cap status and sector dynamics imply potential for both volatility and opportunity in the near term.

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →